ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 110 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,527,000 | -27.7% | 261,993 | 0.0% | 0.62% | -19.0% |
Q2 2021 | $2,112,000 | -12.1% | 261,993 | -9.3% | 0.77% | +7.4% |
Q1 2021 | $2,403,000 | -9.1% | 288,805 | -17.2% | 0.72% | -16.6% |
Q4 2020 | $2,644,000 | -28.9% | 348,805 | 0.0% | 0.86% | -27.4% |
Q3 2020 | $3,718,000 | -29.7% | 348,805 | 0.0% | 1.18% | -48.0% |
Q2 2020 | $5,288,000 | +82.0% | 348,805 | 0.0% | 2.27% | +38.4% |
Q1 2020 | $2,906,000 | -75.4% | 348,805 | -50.0% | 1.64% | -48.9% |
Q4 2019 | $11,790,000 | +82.0% | 697,610 | +100.0% | 3.21% | -12.1% |
Q3 2019 | $6,477,000 | -18.8% | 348,805 | 0.0% | 3.66% | -14.9% |
Q2 2019 | $7,981,000 | +8.9% | 348,805 | 0.0% | 4.29% | +3.2% |
Q1 2019 | $7,332,000 | +82.8% | 348,805 | 0.0% | 4.16% | +53.2% |
Q4 2018 | $4,011,000 | -48.8% | 348,805 | +2.2% | 2.72% | -32.0% |
Q3 2018 | $7,836,000 | +2.9% | 341,450 | 0.0% | 3.99% | +1.8% |
Q2 2018 | $7,614,000 | -7.8% | 341,450 | -5.6% | 3.92% | -7.5% |
Q1 2018 | $8,261,000 | -12.8% | 361,550 | 0.0% | 4.24% | -16.2% |
Q4 2017 | $9,473,000 | -4.1% | 361,550 | -17.8% | 5.06% | -6.3% |
Q3 2017 | $9,878,000 | -9.7% | 440,000 | +10.0% | 5.40% | -13.0% |
Q2 2017 | $10,940,000 | -43.5% | 400,000 | -50.0% | 6.20% | +10.0% |
Q1 2017 | $19,360,000 | +162.1% | 800,000 | +124.7% | 5.64% | +20.0% |
Q4 2016 | $7,387,000 | -7.0% | 356,000 | +22.2% | 4.70% | -3.8% |
Q3 2016 | $7,944,000 | +89.5% | 291,400 | 0.0% | 4.88% | +92.8% |
Q2 2016 | $4,193,000 | +0.1% | 291,400 | 0.0% | 2.53% | -3.3% |
Q1 2016 | $4,187,000 | -39.6% | 291,400 | -9.6% | 2.62% | -36.0% |
Q4 2015 | $6,931,000 | +74.8% | 322,517 | +31.6% | 4.08% | +66.2% |
Q3 2015 | $3,964,000 | -26.2% | 245,017 | +17.8% | 2.46% | -16.5% |
Q2 2015 | $5,368,000 | +14.7% | 208,000 | 0.0% | 2.94% | +13.3% |
Q1 2015 | $4,680,000 | +47.2% | 208,000 | +25.5% | 2.60% | +36.8% |
Q4 2014 | $3,180,000 | -10.6% | 165,700 | 0.0% | 1.90% | -15.1% |
Q3 2014 | $3,559,000 | – | 165,700 | – | 2.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,183,795 | $49,026,000 | 25.32% |
Miura Global Management | 960,000 | $21,552,000 | 5.62% |
Selkirk Management LLC | 440,000 | $9,878,000 | 5.40% |
NEXT CENTURY GROWTH INVESTORS LLC | 505,633 | $11,351,000 | 1.36% |
Geneos Wealth Management Inc. | 407,429 | $9,146,000 | 0.91% |
Trellus Management Company, LLC | 29,186 | $655,000 | 0.90% |
Cannell & Co. | 1,096,239 | $24,611,000 | 0.85% |
CHARTIST INC /CA/ | 64,765 | $1,453,974,000 | 0.68% |
OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,480,000 | 0.58% |
Intrinsic Edge Capital Management LLC | 102,082 | $2,292,000 | 0.45% |